Name | Orelabrutinib |
---|
Description | Orelabrutinib (ICP-022) is a potent, orally active, and irreversible Bruton's tyrosine kinase (BTK) inhibitor. Orelabrutinib has the potential for B-cell malignancies treatment[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C26H25N3O3 |
---|---|
Molecular Weight | 427.50 |